DVAX
Price
$13.33
Change
-$0.00 (-0.00%)
Updated
Feb 21 closing price
Capitalization
1.62B
67 days until earnings call
LFCR
Price
$5.61
Change
-$0.12 (-2.09%)
Updated
Feb 21 closing price
Capitalization
176.87M
38 days until earnings call
Ad is loading...

DVAX vs LFCR

Header iconDVAX vs LFCR Comparison
Open Charts DVAX vs LFCRBanner chart's image
Dynavax Technologies
Price$13.33
Change-$0.00 (-0.00%)
Volume$2.87M
Capitalization1.62B
Lifecore Biomedical
Price$5.61
Change-$0.12 (-2.09%)
Volume$118.65K
Capitalization176.87M
DVAX vs LFCR Comparison Chart
Loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DVAX vs. LFCR commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a Hold and LFCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (DVAX: $12.93 vs. LFCR: $6.00)
Brand notoriety: DVAX and LFCR are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DVAX: 88% vs. LFCR: 58%
Market capitalization -- DVAX: $1.62B vs. LFCR: $176.87M
DVAX [@Pharmaceuticals: Other] is valued at $1.62B. LFCR’s [@Pharmaceuticals: Other] market capitalization is $176.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVAX’s FA Score shows that 1 FA rating(s) are green whileLFCR’s FA Score has 1 green FA rating(s).

  • DVAX’s FA Score: 1 green, 4 red.
  • LFCR’s FA Score: 1 green, 4 red.
According to our system of comparison, DVAX is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DVAX’s TA Score shows that 4 TA indicator(s) are bullish while LFCR’s TA Score has 4 bullish TA indicator(s).

  • DVAX’s TA Score: 4 bullish, 4 bearish.
  • LFCR’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than DVAX.

Price Growth

DVAX (@Pharmaceuticals: Other) experienced а +1.81% price change this week, while LFCR (@Pharmaceuticals: Other) price change was +4.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +77.53%, and the average quarterly price growth was +51.31%.

Reported Earning Dates

DVAX is expected to report earnings on May 01, 2025.

LFCR is expected to report earnings on Apr 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVAX($1.62B) has a higher market cap than LFCR($177M). DVAX YTD gains are higher at: 1.253 vs. LFCR (-19.246). DVAX has higher annual earnings (EBITDA): 9.67M vs. LFCR (-22.64M). DVAX has more cash in the bank: 742M vs. LFCR (4.22M). LFCR has less debt than DVAX: LFCR (157M) vs DVAX (257M). DVAX has higher revenues than LFCR: DVAX (232M) vs LFCR (188M).
DVAXLFCRDVAX / LFCR
Capitalization1.62B177M916%
EBITDA9.67M-22.64M-43%
Gain YTD1.253-19.246-7%
P/E Ratio31.63N/A-
Revenue232M188M123%
Total Cash742M4.22M17,575%
Total Debt257M157M164%
FUNDAMENTALS RATINGS
DVAX vs LFCR: Fundamental Ratings
DVAX
LFCR
OUTLOOK RATING
1..100
1573
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
54100
SMR RATING
1..100
8799
PRICE GROWTH RATING
1..100
4963
P/E GROWTH RATING
1..100
45
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DVAX's Valuation (77) in the Biotechnology industry is in the same range as LFCR (87) in the Industrial Specialties industry. This means that DVAX’s stock grew similarly to LFCR’s over the last 12 months.

DVAX's Profit vs Risk Rating (54) in the Biotechnology industry is somewhat better than the same rating for LFCR (100) in the Industrial Specialties industry. This means that DVAX’s stock grew somewhat faster than LFCR’s over the last 12 months.

DVAX's SMR Rating (87) in the Biotechnology industry is in the same range as LFCR (99) in the Industrial Specialties industry. This means that DVAX’s stock grew similarly to LFCR’s over the last 12 months.

DVAX's Price Growth Rating (49) in the Biotechnology industry is in the same range as LFCR (63) in the Industrial Specialties industry. This means that DVAX’s stock grew similarly to LFCR’s over the last 12 months.

DVAX's P/E Growth Rating (4) in the Biotechnology industry is in the same range as LFCR (5) in the Industrial Specialties industry. This means that DVAX’s stock grew similarly to LFCR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DVAXLFCR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 6 days ago
79%
Bullish Trend 6 days ago
70%
Momentum
ODDS (%)
Bearish Trend 6 days ago
72%
Bullish Trend 6 days ago
71%
MACD
ODDS (%)
Bearish Trend 6 days ago
67%
Bullish Trend 6 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
77%
Bullish Trend 6 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
76%
Bearish Trend 6 days ago
74%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 28 days ago
80%
Bearish Trend 13 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
79%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 6 days ago
70%
View a ticker or compare two or three
Ad is loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with SUPN. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+0.86%
SUPN - DVAX
33%
Loosely correlated
+1.64%
ETON - DVAX
31%
Poorly correlated
+4.36%
VTRS - DVAX
27%
Poorly correlated
+0.56%
AMPH - DVAX
26%
Poorly correlated
-0.87%
COLL - DVAX
23%
Poorly correlated
+0.17%
More

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-1.48%
SHPH - LFCR
31%
Poorly correlated
-2.82%
AQST - LFCR
24%
Poorly correlated
-5.12%
DVAX - LFCR
23%
Poorly correlated
+0.86%
TKNO - LFCR
22%
Poorly correlated
-1.93%
ITCI - LFCR
22%
Poorly correlated
+0.11%
More